Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection

author
created [InstanceEdit:9762563] Stephan, Ralf, 2022-01-27
dbId 9762564
displayName Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection
journal Curr Opin Virol
pages 36-40
pubMedIdentifier 34029993
schemaClass LiteratureReference
title Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection
url http://www.ncbi.nlm.nih.gov/pubmed/34029993
volume 49
year 2021
Cite Us!